Caring Community Cuisine operates with a mission of helping those battling cancer.
cancer
Cancer patients in rural Maine continue to struggle with long travel times to treatment
Two of the state’s most rural counties are without a single oncology practice.
Opening of medical campus at Westbrook’s Rock Row put off to 2025
New England Cancer Specialists and the Dempsey Center are among the tenants expected to move into the mixed-use complex beginning in January.
Biden announces $150 million for research as part of ‘moonshot’ push to fight cancer
In 2022, he set a goal to cut U.S. cancer fatalities by 50% over the next 25 years.
Nonantum heroes take on Tri for a Cure
Nonantum Resort owner and operator Jean Ginn Marvin has taken part in all 17 Tri for a Cure events.
Deer Isle home of late musician Dan Fogelberg is for sale
The waterfront property off Eggemoggin Reach is on the market for $2.4 million, and many of his belongings from the estate will be sold at auction this month.
King Charles III’s openness about cancer has helped him connect with people in year after coronation
Charles has used his illness to highlight the need for early diagnosis and treatment, showing leadership at a time of personal hardship. In the process, people have begun to see him as a more flesh-and-blood character who faces the same challenges as them, not just an archetype of wealth and privilege.
From a Portland hospital bed, this tennis coach with cancer sits courtside for son’s high school debut
Even as he is hospitalized for non-Hodgkin lymphoma treatment, Seth Meyer was able to catch his kid’s first match miles away in Rockport. For this tennis-focused family, love is not nothing – it’s everything.
A blood test to detect cancer? Some patients are using them already.
These new cancer detection blood tests – about 20 are in various stages of development – measure cancer ‘signals,’ which are biological substances shed by cancers such as fragments of tumor DNA.
Many cancer drugs remain unproven 5 years after accelerated approval, a study finds
A study found that between 2013 and 2017, there were 46 cancer drugs granted accelerated approval. Of those, 63% were converted to regular approval even though only 43% demonstrated a clinical benefit in confirmatory trials.